SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is experiencing significant momentum following the FDA approval of Auvelity for the treatment of agitation in Alzheimer's disease, with the company raising its peak sales projection to $8 billion. The community is actively discussing the drug's potential as a first-line therapy, its competitive advantage due to the lack of a black-box warning, and the upcoming quarterly earnings report on August 10, 2026.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is currently navigating a period of uncertainty as traders closely monitor legislative updates regarding the Clarity Act and broader institutional adoption. Community sentiment is deeply divided, balancing excitement over potential institutional rotations and BlackRock's tokenized fund developments against frustration with persistent price range-bound volatility.

Microstrategy Incorporated. The Group's principal activity is to provide business intelligence software that enable companies to analyze raw data stored across their enterprise. The solutions offered by the Group include MicroStrategy 7i, MicroStrategy Intelligence Server, MicroStrategy Web, MicroStrategy Narrowcast Server, MicroStrategy MDX Adapter and MicroStrategy Agent. The Group also offers product support and other services such as technical account management, consulting, education and technical support. These solutions and services are marketed worldwide to the retail, telecommunications, financial services, pharmaceuticals, manufacturing and technology industries. The customers include Bank of Montreal, Ace Hardware Corporation, AT&T, Grange Insurance, AmerisourceBergen Corporation, E.I. Dupont de Nemours and Company, TRX Data Services and US Postal Service.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is at the center of intense debate as traders weigh the impact of ongoing share dilution against the company's aggressive Bitcoin treasury strategy. The community is sharply divided, with bulls betting on a structural breakout tied to potential regulatory progress and institutional accumulation, while bears highlight the risks of dilution and the firm's leveraged position during a period of market consolidation.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

The SPDR S&P Biotech ETF (XBI) is experiencing notable volatility as investors shift capital into the healthcare sector, with active community discussions centering on institutional accumulation, short interest levels, and ongoing clinical trial readouts for small-cap biotech holdings. Despite broader market fluctuations and interest rate concerns, the sector remains a primary focus for traders anticipating potential M&A activity and positive catalysts within the biotech pipeline.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is trending as market participants debate the impact of stalled Clarity Act legislation, leading to polarizing community sentiment between those who view current price action as an accumulation opportunity and those who are frustrated by stagnant performance. While retail investors remain divided over the asset's utility and long-term outlook, the discussion is heavily driven by intense speculation on legislative outcomes and broader liquidity rotations.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is experiencing heightened volatility and community debate as investors react to the delay of the CLARITY Act while monitoring broader market conditions, including macroeconomic shifts and institutional ETF activity. Market participants remain split between those anticipating a major breakout supported by accumulation and those bracing for further downside amid ongoing regulatory uncertainty.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is seeing heightened trading interest as investors anticipate the imminent release of Phase 3 IZAR-1 trial results, with sentiment heavily influenced by expectations of best-in-class efficacy for sonelokimab in psoriatic arthritis. Community members are actively debating potential buyout scenarios and management's strategic communication, while monitoring for a critical data drop that could serve as a major valuation inflection point.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

UCO is experiencing intense volatility as traders react to shifting geopolitical narratives surrounding a potential U.S.-Iran ceasefire and the reopening of the Strait of Hormuz. While some investors view the deal as a major bearish catalyst for crude prices, the community remains divided, with many actively discussing the disconnect between paper-traded oil prices and the reality of disrupted supply chains and depleted global inventories.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

PEPE is currently trending as speculative money flows back into the meme coin sector, with community sentiment split between frustration over stagnant price action and bullish anticipation of a potential breakout. Investors are actively debating the token's long-term viability against other meme projects while monitoring broader market liquidity and crypto-related legislative developments for potential catalysts.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly remains a primary focal point for the investment community following a high-stakes legal dispute with Novo Nordisk over marketing claims and the continued expansion of its dominant GLP-1 obesity franchise. Investors are closely monitoring upcoming earnings and pipeline developments for retatrutide, as they weigh the company's long-term competitive positioning against potential cardiovascular overhangs and broader sector rotations.

statis crypto Watchlist

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Zen Upgrades Texas Ventures Acquisition III (NASDAQ:TVA) to "Hold"

Wall Street Zen raised Texas Ventures Acquisition III from a "sell" rating to a "hold" rating in a research report on Saturday...

Hudson Bay Capital Management LP Sells 917,224 Shares of Texas Ventures Acquisition III Corp $TVA

Hudson Bay Capital Management LP lessened its position in shares of Texas Ventures Acquisition III Corp (NASDAQ:TVA - Free Report) by 65.5% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 482...

Texas Ventures Acquisition III (NASDAQ:TVA) Shares Down 1.1% - Here's What Happened

Texas Ventures Acquisition III (NASDAQ:TVA) Trading Down 1.1% - Here's Why...

Insider Buying: Texas Ventures Acquisition III (NASDAQ:TVA) Director Purchases $1,991,094.67 in Stock

Texas Ventures Acquisition III Corp (NASDAQ:TVA - Get Free Report) Director Mark Angelo acquired 187,309 shares of the stock in a transaction that occurred on Wednesday, February 4th. The shares were...

Texas Ventures Acquisition III (NASDAQ:TVA) Director Purchases $7,967,062.80 in Stock

Texas Ventures Acquisition III Corp (NASDAQ:TVA - Get Free Report) Director Mark Angelo acquired 737,691 shares of the business's stock in a transaction that occurred on Thursday, February 5th. The...

Texas Ventures Acquisition III (NASDAQ:TVA) Director Purchases $1,991,094.67 in Stock

Texas Ventures Acquisition III Corp (NASDAQ:TVA - Get Free Report) Director Mark Angelo bought 187,309 shares of the company's stock in a transaction dated Wednesday, February 4th. The shares were...

Texas Ventures Acquisition III (NASDAQ:TVA) Trading Up 0.1% - Time to Buy?

Texas Ventures Acquisition III (NASDAQ:TVA) Trading Up 0.1% - Here's Why...

Texas Ventures Acquisition III Corp. is a blank check company, which was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on July 26, 2024 and is headquartered in Mountainside, NJ.

Texas Ventures Acquisition III Corp - Ordinary Shares - Class A

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

TVATexas Ventures Acquisition III Corp

Fundamentals

Connect Stocktwits to ChatGPT

Latest TVA News